Hostname: page-component-8448b6f56d-jr42d Total loading time: 0 Render date: 2024-04-19T20:17:03.005Z Has data issue: false hasContentIssue false

Methicillin-resistant Staphylococcus aureus bacteremia during the coronavirus disease 2019 (COVID-19) pandemic: Trends and distinguishing characteristics among patients in a healthcare system in New York City

Published online by Cambridge University Press:  09 September 2022

Saif Aslam
Affiliation:
Division of Infectious Diseases, NYC Health+Hospitals/Kings County, Brooklyn, New York
Habtamu Asrat
Affiliation:
Division of Infectious Diseases, NYC Health+Hospitals/Kings County, Brooklyn, New York
Rina Liang
Affiliation:
Department of Medicine, SUNY-Downstate Medical Center, Brooklyn, New York
Wenqi Qiu
Affiliation:
School of Public Health, SUNY Downstate Medical Center, Brooklyn, New York
Subin Sunny
Affiliation:
Department of Pharmacy Services, NYC Health+Hospitals/Kings County, Brooklyn, New York
Anna Maro
Affiliation:
Division of Infectious Diseases, NYC Health+Hospitals/Kings County, Brooklyn, New York
Marie Abdallah*
Affiliation:
Division of Infectious Diseases, NYC Health+Hospitals/Kings County, Brooklyn, New York
Mary Fornek
Affiliation:
Department of Infection Control and Prevention, NYC Health+Hospitals/Central Office, New York, New York
Briana Episcopia
Affiliation:
Department of Infection Control and Prevention, NYC Health+Hospitals/Kings County, Brooklyn, New York
John Quale
Affiliation:
Division of Infectious Diseases, NYC Health+Hospitals/Kings County, Brooklyn, New York
*
Author for correspondence: Marie Abdallah, E-mail: marie.abdallah@nychhc.org

Abstract

During the pandemic, the rate of healthcare facility–onset methicillin-resistant Staphylococcus aureus (MRSA) bacteremia was 5 times greater in patients admitted with coronavirus disease 2019 (COVID-19). The presence of central lines and mechanical ventilation likely contribute to this increased rate. The number of central-line–associated bacteremia cases may be underestimated in patients with COVID-19.

Type
Concise Communication
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Cole, J, Barnard, E. The impact of the COVID-19 pandemic on healthcare-acquired infections with multidrug-resistant organisms. Am J Infect Cont 2021;49:653654.CrossRefGoogle ScholarPubMed
Wee, LEI, Conceicao, EP, Tan, JY, et al. Unintended consequences of infection prevention and control measures during COVID-19 pandemic. Am J Infect Cont 2021;49:469477.CrossRefGoogle ScholarPubMed
Weiner-Lastinger, LM, Pattabiraman, V, Konnor, RY, et al. The impact of coronavirus disease 2019 (COVID-19) on healthcare-associated infections in 2020: a summary of data reported to the National Healthcare Safety Network. Infect Cont Hosp Epidemiol 2022;43:1225.CrossRefGoogle Scholar
Baker, MA, Sands, KE, Huang, SS, et al. The impact of COVID-19 on healthcare-associated infections. Clin Infect Dis 2021. doi: 10.1093/cid/ciab688.CrossRefGoogle Scholar
Punjabi, CD, Madaline, T, Gendlina, I, Chen, V, Nori, P, Pirofski, LA. Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in respiratory cultures and diagnostic performance of the MRSA nasal polymerase chain reaction (PCR) in patients hospitalized with coronavirus disease 2019 (COVID-19) pneumonia. Infect Cont Hosp Epidemiol 2021;42:11561158.CrossRefGoogle ScholarPubMed
Sturm, LK, Saake, K, Roberts, P, Masoudi, F, Fakih, MG. Impact of COVID-19 pandemic on hospital-onset bloodstream infections (HOBSI) at a large health system. Am J Infect Cont 2022;50:245249.CrossRefGoogle Scholar
Westblade, LF, Simon, MS, Satlin, MJ. Bacterial coinfections in coronavirus disease 2019. Trends Microbiol 2021;29:930941.CrossRefGoogle ScholarPubMed
Cusumano, JA, Dupper, AC, Malik, Y, et al. Staphylococcus aureus bacteremia in patients infected with COVID-19: a case series. Open Forum Infect Dis 2020;7.Google ScholarPubMed
Adalbert, JR, Varshney, K, Tobin, R, Pajaro, R. Clinical outcomes in patients coinfected with COVID-19 and Staphylococcus aureus: a scoping review. BMC Infect Dis 2021;21:985.CrossRefGoogle ScholarPubMed
Maro, A, Asrat, H, Qiu, W, et al. Trends in Clostridioides difficile infection across a public health hospital system in New York City 2019–2021: a cautionary note. Am J Infect Cont 2022. doi: 10.1016/j.ajic.2022.04.015.CrossRefGoogle Scholar